Find the lowest price from 7,500+ FDA-registered pharmacies. Save up to 90%.
⭐ 4.7/5 Customer Rating
🏅 FDA-Registered Pharmacies
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
Blocks histamine H1 receptors directly at target tissues — a second line of action that manages symptoms even when some mediator release occurs.
Semaglutide combined with B12 (methylcobalamin) is one of the most commonly prescribed compounded GLP-1 combinations. B12 is added to address nutrient depletion associated with GLP-1 therapy and to support energy, metabolism, and neurological health during treatment.
Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Semaglutide activates GLP-1 receptors in the pancreas, brain, and gut — stimulating insulin release, suppressing glucagon, slowing gastric emptying, and reducing appetite. Methylcobalamin (B12) is added as the bioactive form of vitamin B12, supporting methylation, red blood cell production, and nerve function that may be impaired during GLP-1 therapy.
No commercially available product combines semaglutide with B12. Compounding allows prescribers to address GLP-1-associated nutrient depletion in a single injection, simplifying the patient's regimen and improving adherence. Custom dose titration schedules and alternative delivery forms (sublingual, troche) are also only available through compounding.
Compounded semaglutide with B12 combines a GLP-1 receptor agonist with methylcobalamin — the bioactive, methylated form of vitamin B12. This combination has become one of the most widely prescribed compounded GLP-1 formulations in the United States.
GLP-1 agonists like semaglutide can reduce appetite significantly, leading to decreased food intake and potential nutrient gaps. B12 deficiency is a recognized concern during extended GLP-1 therapy due to reduced dietary intake and altered gastrointestinal absorption from delayed gastric emptying.
By combining both agents in a single preparation, compounding pharmacies allow patients to receive their GLP-1 therapy and B12 supplementation in one injection — reducing injection burden and simplifying their treatment protocol.
Semaglutide — GLP-1 Receptor Activation
Semaglutide binds to GLP-1 receptors on pancreatic beta cells, hypothalamic neurons, and gastric smooth muscle. This stimulates glucose-dependent insulin secretion, suppresses inappropriate glucagon release, delays gastric emptying (promoting satiety), and acts on hypothalamic appetite centers to reduce hunger and caloric intake.
Methylcobalamin — Neurological and Metabolic Support
Methylcobalamin is a coenzyme required for methionine synthase activity, converting homocysteine to methionine — a critical step in the methylation cycle. It supports myelin synthesis, red blood cell formation, and DNA repair. During significant caloric restriction from GLP-1 therapy, maintaining adequate B12 status helps prevent fatigue, neuropathy, and cognitive changes.
Prescribed for patients with a documented clinical need for compounded semaglutide who also benefit from B12 supplementation:
BIND THIS TO: Mechanism Text CMS field (Rich Text). Then delete this paragraph and add a Rich Text element instead.
Metabolic syndrome, PCOS (insulin resistance component), non-alcoholic fatty liver disease (NAFLD), cardiovascular risk reduction in patients with established atherosclerotic disease
⚠️ Dosing should be determined by your prescriber. The information below is general guidance only.
Typical semaglutide titration with B12:
Weeks 1–4: Semaglutide 0.25mg + B12 1mg weekly
Weeks 5–8: Semaglutide 0.5mg + B12 1mg weekly
Weeks 9–12: Semaglutide 1.0mg + B12 1mg weekly
Weeks 13+: Semaglutide 1.7–2.4mg + B12 1mg weekly (as tolerated)
Dosing is individualized by the prescribing provider. B12 dose typically remains constant while semaglutide is titrated upward.
Start at the lowest semaglutide dose and increase every 4 weeks as tolerated. The most common side effects (nausea, constipation) are dose-dependent and typically improve with gradual titration. B12 does not contribute to GI side effects and may help with energy levels during the adjustment period. If nausea is significant, the prescriber may slow the titration schedule.
Subcutaneous Injection — The most common and best-studied form. Semaglutide and B12 are combined in a single vial for weekly injection. Pre-filled syringes or multi-dose vials are available depending on the pharmacy.
Sublingual Tablets — Dissolved under the tongue for absorption. A needle-free alternative for patients who prefer not to inject. Absorption rates differ from injectable delivery.
Troches — Flavored lozenges that dissolve in the mouth. Another needle-free option, though bioavailability may differ from injectable forms.
From semaglutide (most common):
From B12 (methylcobalamin):
GI side effects are dose-dependent and usually resolve with gradual titration. Report persistent vomiting, severe abdominal pain, or signs of pancreatitis to your provider immediately.
Compounded semaglutide + B12 is a 503A patient-specific preparation requiring a valid prescription. Neither the combination nor the compounded form is FDA-approved, though both active ingredients are well-established. The FDA resolved the semaglutide shortage in February 2025; compounding remains legal for patients with documented clinical needs. Patients should verify their pharmacy is licensed and conducts third-party sterility and potency testing.
GLP-1 agonists significantly reduce appetite and food intake, which can lead to nutrient gaps including B12 deficiency. Methylcobalamin supports energy production, nerve health, and red blood cell formation. Combining both in one injection simplifies the treatment regimen.
No. Compounded medications are not individually FDA-approved. However, both semaglutide and methylcobalamin are well-established pharmaceutical ingredients. The combination is prepared by licensed compounding pharmacies under a valid prescription.
Typical pricing ranges from $179 to $449 per month depending on the semaglutide dose, pharmacy, and whether additional consultation fees apply. Compounding Finder helps you compare options from multiple licensed pharmacies.
Yes. Licensed compounding pharmacies can prepare semaglutide combinations for patients with documented clinical needs — such as a requirement for non-standard dosing, alternative delivery forms, or combination formulations not commercially available.
The most common form is a subcutaneous injection administered weekly. Some pharmacies also offer sublingual tablets or troches as needle-free alternatives, though injectable delivery has the most clinical evidence.
Yes. Compounded semaglutide + B12 requires a valid prescription from a licensed healthcare provider. Be cautious of any source offering GLP-1 medications without requiring a prescription.
1. Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844.
2. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
3. Pflipsen MC, et al. The Prevalence of Vitamin B12 Deficiency in Patients with Type 2 Diabetes. J Am Board Fam Med. 2009;22(5):528-534.
4. Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician. 2017;96(6):384-389.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
